Thu. 8 Feb 2024, 4:38pm ET
Benzinga
Earnings, Earnings Beats, News
Applied DNA Sciences (NASDAQ:APDN) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.31) by 70.97 percent. This is a 70 percent increase over losses of $(0.30) per share from the same period last year. The company reported quarterly sales of $891.16 thousand which beat the analyst consensus estimate of $776.00 thousand by 14.84 percent. This is a 83.07 percent decrease over sales of $5.26 million the same period last year.